Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-α

Journal of Molecular Endocrinology

Volumn 44, Issue 4, 2010, Pages 237-246

  Sobrino, Agua ^a   Oviedo, Pilar J ^a   Novella, Susana ^a,b   Laguna Fernandez, Andrés ^a   Bueno, Carlos ^a,b   García Pérez, Miguel Angel ^a   Tarín, Juan J ^b   Cano, Antonio ^b   Hermenegildo, Carlos ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIARYLPROPIONITRILE; ESTERASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; MESSENGER RNA; METHYLPIPERIDINOPYRAZOLE; PHOSPHOLIPASE; PHOSPHOLIPASE A2 GROUP IVA; PHOSPHOLIPASE A2 GROUP IVB; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; THROMBOXANE A2; THROMBOXANE SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; WESTERN BLOTTING;

CELLS, CULTURED; CYCLOOXYGENASE 1; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GROUP IV PHOSPHOLIPASES A2; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; THROMBOXANE A2;

EID: 77950209694     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-09-0112     Document Type: Article

References (47)

1. Akarasereenont P, Techatraisak K, Thaworn A & Chotewuttakorn S 2000 The induction of cyclooxygenase-2 by 17beta-estradiol in endothelial cells is mediated through protein kinase C. Inflammation Research 49 460-465.
2. Arnal JF, Gourdy P, Elhage R, Garmy-Susini B, Delmas E, Brouchet L, Castano C, Barreira Y, Couloumiers JC, Prats H et al. 2004 Estrogens and atherosclerosis. European Journal of Endocrinology 150 113-117.
3. Barrett-Connor E & Grady D 1998 Hormone replacement therapy, heart disease, and other considerations. Annual Review of Public Health 19 55-72.
4. Billon-Galés A, Fontaine C, Filipe C, Douin-Echinard V, Fouque MJ, Flouriot G, Gourdy P, Lenfant F, Laurell H, Krust A et al. 2009 The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol. PNAS 106 2053-2058.
5. Bunting S, Moncada S & Vane JR 1983 The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. British Medical Bulletin 39 271-276.
6. Cano A & Hermenegildo C 2000 Modulation of the oestrogen receptor: a process with distinct susceptible steps. Human Reproduction Update 6 207-211.
7. Cano A, Hermenegildo C, Oviedo P & Tarin JJ 2007 The risk for cardiovascular disease in women: from estrogens to selective estrogen receptor modulators. Frontiers in Bioscience 12 49-68.
8. Caughey GE, Cleland LG, Gamble JR & James MJ 2001 Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2. Journal of Biological Chemistry 276 37839-37845.
9. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME & Shaul PW 1999 Estrogen receptor alpha mediates the non-genomic activation of endothelial nitric oxide synthase by estrogen. Journal of Clinical Investigation 103 401-406.
10. Doroudi R, Gan LM, Selin Sjogren L & Jern S 2000 Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model. Biochemical and Biophysical Research Communications 269 257-264.
11. Gibson LL, Hahner L, Osborne-Lawrence S, German Z, Wu KK, Chambliss KL & Shaul PW 2005 Molecular basis of estrogen-induced cyclooxygenase type 1 upregulation in endothelial cells. Circulation Research 96 518-525.
12. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S et al. 2002 Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). Journal of the American Medical Association 288 49-57.
13. Harris HA 2007 Estrogen receptor-b: recent lessons from in vivo studies. Molecular Endocrinology 21 1-13.
14. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC & Bender JR 2003 Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. Journal of Biological Chemistry 278 2118-2123.
15. Henriksson P, Stege R & Green K 1996 Profound decrease of in vivo formation of thromboxane during oestrogen therapy. European Journal of Clinical Investigation 26 1186-1188.
16. Hermenegildo C, Garcia-Martinez MC, Tarin JJ & Cano A 2002 Estradiol reduces F2alpha -isoprostane production in cultured human endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 283 H2644-H2649.
17. Hermenegildo C, Oviedo PJ & Cano A 2006 Cyclooxygenases regulation by estradiol on endothelium. Current Pharmaceutical Design 12 205-215.
18. -/- mice. Journal of Clinical Investigation 107 333-340.
19. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B & Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 280 605-613.
20. Jun SS, Chen Z, Pace MC & Shaul PW 1998 Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. Journal of Clinical Investigation 102 176-183.
21. Kim KH & Bender JR 2009 Membrane-initiated actions of estrogen on the endothelium. Molecular and Cellular Endocrinology 308 3-8.
22. Korita D, Itoh H, Sagawa N, Yura S, Yoshida M, Kakui K, Takemura M & Fujii S 2004 17[beta]-estradiol up-regulates prostacyclin production in cultured human uterine myometrial cells via augmentation of both cyclooxygenase-1 and prostacyclin synthase expression. Journal of the Society for Gynecologic Investigation 11 457-464.
23. Krom YD, Pires NMM, Jukema JW, de Vries MR, Frants RR, Havekes LM, van Dijk KW & Quax PHA 2007 Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists. Cardiovascular Research 73 217-226.
24. Li M, Kuo L & Stallone JN 2008 Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. American Journal of Physiology. Heart and Circulatory Physiology 294 H2444-H2455.
25. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 196 265-275.
26. Mendelsohn ME & Karas RH 2005 Molecular and cellular basis of cardiovascular gender differences. Science 308 1583-1587.
27. Meyer MR & Barton M 2009 ER{alpha}, ER{beta}, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovascular Research 83 605-610.
28. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L & Ylikorkala O 1995 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. Journal of Clinical Endocrinology and Metabolism 80 1832-1836.
29. Monsalve E, Oviedo PJ, Garcia-Perez MA, Tarin JJ, Cano A & Hermenegildo C 2007 Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Cardiovascular Research 73 66-72.
30. Mueck AO, Seeger H, Ludtke R, Graser T & Wallwiener D 2001 Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest. Maturitas 38 305-313.
31. Oliveira RL, Aldrighi JM, Gebara OE, Rocha TRF, D'Amico E, Rosano GMC & Ramires JA 2005 Postmenopausal hormone replacement therapy increases plasmatic thromboxane [beta]2. International Journal of Cardiology 99 449-454.
32. Ospina JA, Krause DN & Duckles SP 2002 17beta-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 33 600-605.
33. Ost M, Uhl E, Carlsson M, Gidlof A, Soderkvist P & Sirsjo A 1998 Expression of mRNA for phospholipase A2, cyclooxygenases, and lipoxygenases in cultured human umbilical vascular endothelial and smoothmuscle cells and in biopsies from umbilical arteries and veins. Journal of Vascular Research 35 150-155.
34. Oviedo PJ, Hermenegildo C & Cano A 2004 Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: implication of COX-1 and COX-2. Menopause 11 430-437.
35. Oviedo PJ, Hermenegildo C, Tarin JJ & Cano A 2007 Raloxifene increases proliferation of human endothelial cells in association with increased gene expression of cyclins A and B1. Fertility and Sterility 88 326-332.
36. Pfaffl MW, Horgan GW & Dempfle L 2002 Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 30 e36.
37. Rupnow HL, Phernetton TM, Modrick ML, Wiltbank MC, Bird IM & Magness RR 2002 Endothelial vasodilator production by uterine and systemic arteries. VIII. Estrogen and progesterone effects on cPLA2, COX-1, and PGIS protein expression. Biology of Reproduction 66 468-474.
38. Sellers MM & Stallone JN 2008 Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure. American Journal of Physiology. Heart and Circulatory Physiology 294 H1978-H1986.
39. Sherman TS, Chambliss KL, Gibson LL, Pace MC, Mendelsohn ME, Pfister SL & Shaul PW 2002 Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. American Journal of Respiratory Cell and Molecular Biology 26 610-616.
40. Stewart KG, Zhang Y & Davidge ST 1999 Estrogen decreases prostaglandin H synthase products from endothelial cells. Journal of the Society for Gynecologic Investigation 6 322-327.
41. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K & Rubanyi GM 1997 Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349 1146-1147.
42. Toth B, Scholz C, Saadat G, Geller A, Schulze S, Mylonas I, Friese K & Jeschke U 2008 Estrogen receptor modulators and estrogen receptor beta immunolabelling in human umbilical vein endothelial cells. Acta Histochemica 111 508-519.
43. Traupe T, Stettler CD, Li H, Haas E, Bhattacharya I, Minotti R & Barton M 2007 Distinct roles of estrogen receptors α and β mediating acute vasodilation of epicardial coronary arteries. Hypertension 49 1364-1370.
44. Turgeon JL, Carr MC, Maki PM, Mendelsohn ME & Wise PM 2006 Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: insights from basic science and clinical studies. Endocrine Reviews 27 575-605.
45. Ueno N, Murakami M, Tanioka T, Fujimori K, Tanabe T, Urade Y & Kudo I 2001 Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. Journal of Biological Chemistry 276 34918-34927.
46. Wagner AH, Schroeter MR & Hecker M 2001 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB Journal 15 2121-2130.
47. Widder J, Pelzer T, von Poser-Klein C, Hu K, Jazbutyte V, Fritzemeier KH, Hegele-Hartung C, Neyses L & Bauersachs J 2003 Improvement of endothelial dysfunction by selective estrogen receptor-α stimulation in ovariectomized SHR. Hypertension 42 991-996.